Kauffman Michael Insider Trading
Get the latest insider transactions of Kauffman Michael. Kauffman Michael is Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Chief Executive Officer in Karyopharm Therapeutics Inc. ($KPTI) and Director in Verastem, Inc. ($VSTM) and Director in Kezar Life Sciences, Inc. ($KZR). Discover the current value of Kauffman Michael shares.
Address: C/O COMBINATORX, INCORPORATED 245 FIRST STREET, 16TH FLOOR CAMBRIDGE 02142MA
Kauffman Michael is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
CRXX | EPIRUS Biopharmaceuticals, Inc. | Director | 0 | 0.00 |
VSTM | Verastem, Inc. | Director | 4,000 | 4,960.00 |
KPTI | Karyopharm Therapeutics Inc. | Chief Executive Officer | 714,826 | 7,377,004.32 |
INFI | INFINITY PHARMACEUTICALS, INC. | Director | 0 | 0.00 |
KZR | Kezar Life Sciences, Inc. | Director | 63,690 |
Insider Trading Transactions of Kauffman Michael
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.39 | 4,000 | 49,553 | 714,826 |
Mar 01 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.00 | 57,200 | 0 | 718,826 |
Mar 01 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.00 | 57,200 | 0 | 920,152 |
Mar 01 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 14.56 | 153,500 | 2,234,960 | 153,500 |
Mar 01 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 14.56 | 153,500 | 2,234,960 | 153,500 |
Feb 22 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.83 | 9,495 | 140,822 | 575,126 |
Feb 22 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.83 | 9,495 | 140,822 | 776,452 |
Feb 09 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.00 | 14,300 | 0 | 569,422 |
Feb 09 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.00 | 14,300 | 0 | 770,789 |
Feb 09 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 14,300 | 0 | 42,900 |
Feb 09 2021 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 14,300 | 0 | 42,900 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 1,424 | 47 | 757,913 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 6,076 | 201 | 763,989 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.89 | 7,500 | 111,683 | 756,489 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 1,424 | 47 | 0 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 6,076 | 201 | 0 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 1,424 | 47 | 757,913 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 6,076 | 201 | 763,989 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.89 | 7,500 | 111,683 | 756,489 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 1,424 | 47 | 0 |
Oct 14 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 6,076 | 201 | 0 |
Aug 18 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 1,477 | 49 | 757,966 |
Aug 18 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 15.00 | 1,477 | 22,155 | 756,489 |
Aug 18 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 1,477 | 49 | 6,076 |
Jul 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 7,500 | 248 | 763,989 |
Jul 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 19.43 | 7,500 | 145,723 | 756,489 |
Jul 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 7,500 | 248 | 1,424 |
Jul 13 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 7,500 | 35,640 | 562,622 |
Jul 13 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.98 | 7,200 | 136,627 | 555,422 |
Jul 13 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 19.71 | 300 | 5,912 | 555,122 |
Jul 13 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 7,500 | 35,640 | 763,989 |
Jul 13 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 19.53 | 7,500 | 146,487 | 756,489 |
Jul 13 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 7,500 | 35,640 | 333,561 |
Jul 13 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 7,500 | 35,640 | 377,803 |
Jun 26 2020 | KZR | Kezar Life Sciences, Inc. | Kauffman Michael | Director | Option Exercise | 5.60 | 8,896 | 49,818 | 8,896 |
Jun 24 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 7,500 | 248 | 763,989 |
Jun 24 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 20.00 | 7,500 | 150,000 | 756,489 |
Jun 24 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 7,500 | 248 | 8,924 |
Jun 18 2020 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | 1.77 | 25,000 | 44,250 | 25,000 |
Jun 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 7,143 | 236 | 763,632 |
Jun 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 16.38 | 7,143 | 116,996 | 756,489 |
Jun 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 357 | 12 | 756,846 |
Jun 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 16.20 | 357 | 5,783 | 756,489 |
Jun 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 7,143 | 236 | 16,424 |
Jun 17 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 357 | 12 | 0 |
Jun 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 7,500 | 35,640 | 562,622 |
Jun 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.13 | 7,500 | 135,944 | 555,122 |
Jun 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 7,500 | 35,640 | 763,989 |
Jun 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.50 | 7,500 | 138,746 | 756,489 |
Jun 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 7,500 | 35,640 | 341,061 |
Jun 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 7,500 | 35,640 | 385,303 |
May 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 7,500 | 248 | 763,989 |
May 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.65 | 7,500 | 139,841 | 756,489 |
May 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 7,500 | 248 | 763,989 |
May 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 20.00 | 7,500 | 150,000 | 756,489 |
May 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 7,500 | 248 | 7,857 |
May 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 7,500 | 248 | 357 |
Apr 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 565,122 |
Apr 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 20.64 | 10,000 | 206,404 | 555,122 |
Apr 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 766,489 |
Apr 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.61 | 10,000 | 186,115 | 756,489 |
Apr 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 356,061 |
Apr 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 400,303 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 565,122 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 22.11 | 7,932 | 175,365 | 557,190 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 22.64 | 2,068 | 46,821 | 555,122 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 766,489 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 22.58 | 7,000 | 158,054 | 759,489 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 22.38 | 3,000 | 67,141 | 756,489 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 366,061 |
Mar 11 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 410,303 |
Feb 21 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 16.48 | 8,817 | 145,321 | 555,122 |
Feb 21 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 16.48 | 8,817 | 145,321 | 756,489 |
Feb 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.00 | 21,800 | 0 | 563,939 |
Feb 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.00 | 21,800 | 0 | 765,306 |
Feb 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 21,800 | 0 | 65,400 |
Feb 19 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 21,800 | 0 | 65,400 |
Feb 07 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 18.00 | 153,500 | 2,763,000 | 153,500 |
Feb 07 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 18.00 | 153,500 | 2,763,000 | 153,500 |
Feb 07 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 57,200 | 0 | 57,200 |
Feb 07 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 57,200 | 0 | 57,200 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 552,139 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 19.19 | 10,000 | 191,880 | 542,139 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 753,506 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.57 | 10,000 | 185,705 | 743,506 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 0.00 | 17,313 | 0 | 0 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 0.00 | 17,313 | 0 | 0 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 386,061 |
Jan 10 2020 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 430,303 |
Dec 11 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 539,767 |
Dec 11 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 15.99 | 10,000 | 159,896 | 529,767 |
Dec 11 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 741,134 |
Dec 11 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 17.02 | 10,000 | 170,210 | 731,134 |
Dec 11 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 396,061 |
Dec 11 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 440,303 |
Nov 12 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 539,767 |
Nov 12 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.76 | 10,000 | 147,610 | 529,767 |
Nov 12 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 741,134 |
Nov 12 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.63 | 10,000 | 146,254 | 731,134 |
Nov 12 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 406,061 |
Nov 12 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 450,303 |
Nov 05 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 539,767 |
Nov 05 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.00 | 10,000 | 120,000 | 529,767 |
Nov 05 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 741,134 |
Nov 05 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.00 | 10,000 | 120,000 | 731,134 |
Nov 05 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 416,061 |
Nov 05 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 460,303 |
Sep 17 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 539,767 |
Sep 17 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.00 | 10,000 | 120,000 | 529,767 |
Sep 17 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 741,134 |
Sep 17 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.00 | 10,000 | 120,000 | 731,134 |
Sep 17 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 426,061 |
Sep 17 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 470,303 |
Jun 27 2019 | KZR | Kezar Life Sciences, Inc. | Kauffman Michael | Director | Option Exercise | 7.63 | 8,896 | 67,876 | 8,896 |
Jun 25 2019 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | 1.81 | 25,000 | 45,250 | 25,000 |
Jun 25 2019 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | 1.81 | 25,000 | 45,250 | 25,000 |
Jun 14 2019 | INFI | INFINITY PHARMACEUTICALS, ... | Kauffman Michael | Director | Option Exercise | 1.60 | 30,000 | 48,000 | 30,000 |
Feb 19 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 9.21 | 231,200 | 2,129,352 | 231,200 |
Feb 19 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 9.21 | 231,200 | 2,129,352 | 231,200 |
Feb 19 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 87,200 | 0 | 87,200 |
Feb 19 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.00 | 87,200 | 0 | 87,200 |
Jan 09 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 12,500 | 413 | 743,634 |
Jan 09 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 10.23 | 12,500 | 127,824 | 731,134 |
Jan 09 2019 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 12,500 | 413 | 15,357 |
Dec 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 12,500 | 413 | 726,010 |
Dec 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 10.11 | 12,500 | 126,423 | 713,510 |
Dec 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 12,500 | 413 | 27,857 |
Nov 27 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 9,600 | 45,619 | 521,743 |
Nov 27 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 11.00 | 9,600 | 105,600 | 512,143 |
Nov 27 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 9,600 | 45,619 | 436,061 |
Nov 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 400 | 1,901 | 512,543 |
Nov 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 11.14 | 400 | 4,455 | 512,143 |
Nov 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 400 | 1,901 | 445,661 |
Nov 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 12,500 | 413 | 726,010 |
Nov 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 11.65 | 12,500 | 145,593 | 713,510 |
Nov 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 12,500 | 413 | 40,357 |
Oct 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 522,143 |
Oct 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.63 | 10,000 | 126,304 | 512,143 |
Oct 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 446,061 |
Oct 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 1,764 | 58 | 715,274 |
Oct 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 10,736 | 354 | 726,010 |
Oct 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 15.39 | 6,500 | 100,066 | 719,510 |
Oct 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 16.13 | 6,000 | 96,767 | 713,510 |
Oct 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 1,764 | 58 | 0 |
Oct 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 10,736 | 354 | 52,857 |
Oct 02 2018 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Buy | 7.49 | 4,000 | 29,960 | 4,000 |
Oct 02 2018 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Buy | 0.00 | 4,000 | 0 | 8,000 |
Sep 18 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 522,143 |
Sep 18 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.26 | 10,000 | 182,615 | 512,143 |
Sep 18 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 456,061 |
Sep 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 12,500 | 413 | 726,010 |
Sep 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 19.31 | 12,500 | 241,384 | 713,510 |
Sep 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 12,500 | 413 | 1,764 |
Aug 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 10,000 | 47,520 | 522,143 |
Aug 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 17.46 | 10,000 | 174,568 | 512,143 |
Aug 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 10,000 | 47,520 | 466,061 |
Aug 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 12,500 | 413 | 726,010 |
Aug 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.04 | 12,500 | 225,556 | 713,510 |
Aug 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 12,500 | 413 | 14,264 |
Jul 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 1 | 0 | 512,144 |
Jul 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 5,757 | 1,520 | 517,901 |
Jul 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 4.75 | 4,242 | 20,158 | 522,143 |
Jul 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.27 | 10,000 | 182,686 | 512,143 |
Jul 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 1 | 0 | 0 |
Jul 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 5,757 | 1,520 | 0 |
Jul 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 4.75 | 4,242 | 20,158 | 476,061 |
Jul 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 12,500 | 413 | 726,010 |
Jul 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.72 | 12,500 | 233,990 | 713,510 |
Jul 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 12,500 | 413 | 26,764 |
Jun 27 2018 | KZR | Kezar Life Sciences, Inc. | Kauffman Michael | Director | Buy | 0.00 | 10,516 | 0 | 63,690 |
Jun 27 2018 | KZR | Kezar Life Sciences, Inc. | Kauffman Michael | Director | Option Exercise | 0.00 | 10,516 | 0 | 0 |
Jun 27 2018 | KZR | Kezar Life Sciences, Inc. | Kauffman Michael | Director | Buy | 0.00 | 10,516 | 0 | 63,690 |
Jun 27 2018 | KZR | Kezar Life Sciences, Inc. | Kauffman Michael | Director | Option Exercise | 0.00 | 10,516 | 0 | 0 |
Jun 19 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 522,143 |
Jun 19 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 18.66 | 10,000 | 186,558 | 512,143 |
Jun 19 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 5,757 |
Jun 14 2018 | INFI | INFINITY PHARMACEUTICALS, ... | Kauffman Michael | Director | Option Exercise | 1.75 | 20,000 | 35,000 | 20,000 |
Jun 11 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 9,697 | 2,560 | 723,207 |
Jun 11 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.03 | 303 | 10 | 723,510 |
Jun 11 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 17.30 | 10,000 | 172,991 | 713,510 |
Jun 11 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 9,697 | 2,560 | 0 |
Jun 11 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.03 | 303 | 10 | 7,553 |
May 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 522,143 |
May 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 19.39 | 10,000 | 193,870 | 512,143 |
May 21 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 15,757 |
May 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 723,510 |
May 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 16.77 | 10,000 | 167,747 | 713,510 |
May 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 9,697 |
Apr 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 522,143 |
Apr 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.79 | 10,000 | 147,878 | 512,143 |
Apr 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 2,424 | 640 | 0 |
Apr 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 7,576 | 2,000 | 18,181 |
Apr 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 723,510 |
Apr 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.48 | 10,000 | 124,829 | 713,510 |
Apr 10 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 19,697 |
Mar 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 522,143 |
Mar 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 15.29 | 10,000 | 152,895 | 512,143 |
Mar 20 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 2,424 |
Mar 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 723,510 |
Mar 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 16.15 | 10,000 | 161,463 | 713,510 |
Mar 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 9,394 | 2,480 | 0 |
Mar 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 606 | 160 | 29,697 |
Feb 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 522,143 |
Feb 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 14.79 | 10,000 | 147,872 | 512,143 |
Feb 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 12,424 |
Feb 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 723,510 |
Feb 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 12.50 | 10,000 | 125,048 | 713,510 |
Feb 08 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 9,394 |
Jan 25 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 10.45 | 200,000 | 2,090,000 | 200,000 |
Jan 25 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 10.45 | 200,000 | 2,090,000 | 200,000 |
Jan 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 522,143 |
Jan 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 10.09 | 10,000 | 100,882 | 512,143 |
Jan 22 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 22,424 |
Jan 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 723,510 |
Jan 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 10.08 | 10,000 | 100,769 | 713,510 |
Jan 09 2018 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 19,394 |
Dec 20 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 522,143 |
Dec 20 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 9.16 | 10,000 | 91,553 | 512,143 |
Dec 20 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 32,424 |
Dec 08 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Buy | 0.26 | 10,000 | 2,640 | 723,510 |
Dec 08 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Sell | 10.39 | 10,000 | 103,903 | 713,510 |
Dec 08 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 0.26 | 10,000 | 2,640 | 29,394 |
Jun 15 2017 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | 2.09 | 25,000 | 52,250 | 25,000 |
Apr 06 2017 | INFI | INFINITY PHARMACEUTICALS, ... | Kauffman Michael | Director | Option Exercise | 2.80 | 40,000 | 112,000 | 40,000 |
Jan 24 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 10.39 | 250,000 | 2,597,500 | 250,000 |
Jan 24 2017 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 10.39 | 250,000 | 2,597,500 | 250,000 |
Jun 16 2016 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | 1.37 | 25,000 | 34,250 | 25,000 |
Feb 17 2016 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Sell | 10.96 | 930 | 10,192 | 2,070 |
Feb 17 2016 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Sell | 6.46 | 2,070 | 13,374 | 0 |
Jan 20 2016 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 6.54 | 170,000 | 1,111,800 | 170,000 |
Jan 20 2016 | KPTI | Karyopharm Therapeutics I ... | Kauffman Michael | Chief Executive Offic ... | Option Exercise | 6.54 | 170,000 | 1,111,800 | 170,000 |
Jun 16 2015 | VSTM | Verastem, Inc. | Kauffman Michael | Director | Option Exercise | 7.99 | 17,969 | 143,572 | 17,969 |
Jun 05 2006 | CRXX | EPIRUS Biopharmaceuticals ... | Kauffman Michael | Director | Option Exercise | 8.29 | 22,857 | 189,485 | 22,857 |